
    
      A Phase 3, Multicenter, Double Blind, Active Controlled, Randomized Study to Evaluate the
      Efficacy and Safety of Zabofloxacin for Patients with acute bacterial exacerbation of Chronic
      obstructive pulmonary disease.
    
  